ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 62 filers reported holding ORAMED PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,220 | -41.7% | 2,000 | -20.0% | 0.00% | -50.0% |
| Q2 2023 | $8,950 | +36.9% | 2,500 | -16.7% | 0.00% | 0.0% |
| Q1 2023 | $6,540 | -81.9% | 3,000 | 0.0% | 0.00% | -77.8% |
| Q4 2022 | $36,090 | +89.9% | 3,000 | 0.0% | 0.01% | +80.0% |
| Q3 2022 | $19,000 | +35.7% | 3,000 | 0.0% | 0.01% | +25.0% |
| Q2 2022 | $14,000 | -46.2% | 3,000 | 0.0% | 0.00% | -50.0% |
| Q1 2022 | $26,000 | -39.5% | 3,000 | 0.0% | 0.01% | -33.3% |
| Q4 2021 | $43,000 | -34.8% | 3,000 | 0.0% | 0.01% | -40.0% |
| Q3 2021 | $66,000 | +22.2% | 3,000 | -25.0% | 0.02% | +25.0% |
| Q2 2021 | $54,000 | – | 4,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MORGAN JESS S & CO INC | 315,301 | $1,444,000 | 1.50% |
| Private Portfolio Partners LLC | 54,010 | $247,366 | 0.07% |
| Knoll Capital Management, LLC | 20,000 | $92,000 | 0.05% |
| Urban Wealth Management, LLC | 2,858 | $13,000 | 0.04% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 100,216 | $459,000 | 0.04% |
| XTX Topco Ltd | 18,174 | $83,000 | 0.03% |
| Rossmore Private Capital | 40,661 | $186,000 | 0.03% |
| Ergoteles LLC | 224,700 | $1,029,000 | 0.03% |
| ETF MANAGERS GROUP, LLC | 87,365 | $393,000 | 0.01% |
| Belvedere Trading LLC | 40,690 | $343,000 | 0.01% |